Why Choose Cell CareWith Cell Care in New Zealand, you now have access to:
Cell Care is licensed by Medsafe and the Therapeutic Goods Administration Australia and is a leading cord blood and tissue bank in:
Cell Care has collected and stored cord blood and tissue stem cells for over 200,000 families. We look forward to providing New Zealand expectant parents with a more affordable and innovative cord blood banking service.
|
|
The Cell Care Group |
Cord Bank |
|
Total newborn collections stored |
200,000 |
Approx. 12,000 |
|
Deposit at enrolment |
$99 |
$145 |
| Upfront price: cord blood on annual plan | $1,900 | $2,100 |
| Cord Blood annual storage fee | $190 | $225 |
| Flexible Prepaid payment plans offered | ✔ | - |
| Courier costs | Included | Variable |
| Full refund if collection does not proceed | ✔ | - |
| Clinical trial sponsorship | ✔ | - |
| Number of releases | 80+ | 8 |
| Accredited with Medsafe | ✔ | ✔ |
Cord blood stored with Cell Care has been used (released) in place of bone marrow to regenerate the blood and immune systems after being damaged by diseases like Thalassaemia. We have also released cord blood in the setting of clinical trials.
Cell Care is focused on increasing the potential use of stem cells by partnering with leading research institutions to establish approved clinical trials in regenerative medicine. These groundbreaking trials only use cord blood stem cells processed by Cell Care as a way of ensuring consistent quality.
Importantly, there are no charges incurred to release your cord blood for regulator-approved use(s) and Cell Care will deliver it using dedicated medical transportation to any hospital in the world; free of charge.
Cell Care has a steadfast commitment to the ongoing development of stem cell therapy science and research. We take pride in the fact that we are the only cord blood and tissue bank in Australia and New Zealand participating in cell therapy clinical trials.
Cell Care, the leader in cord blood banking in Australia, educates thousands of expectant parents in the current uses and future potential of umbilical cord stem cells. With more information, expectant parents make better informed decisions.
Cell Care's highly experienced client services team guides parents through every stage of the cord blood and tissue storage process. We provide in-depth information and ongoing updates as to how the science of stem cell treatments and research is evolving.
Cell Care is the leader in cord blood and tissue innovation. We are the only company investing in cord blood clinical trials. Cell Care is the first to offer Australian and New Zealand families the option to store cord tissue which will potentially expand future therapy options.
Cell Care operates in New Zealand with a Medsafe approved manufacturing licence. In Australia, Cell Care is licenced by the Therapeutic Goods Administration (TGA).
In Canada, Cell Care’s subsidiary Insception Biosciences Inc. operates with certifications provided by AABB, Netcord-FACT and Health Canada.
License number – 137/21/1
License number - MI-2009-LI-04618-3
Certificate number – 100042
Pregnancy and birth can be an unpredictable process and this may impact the volume of cord blood collected at the time of birth. Cell Care does not use a minimum collection volume to determine if your cord blood sample will be stored. Rather, the number of stem cells and their viability will dictate the storage potential.
Cell Care use state of the art equipment including flow cytometers and cell impedance counters to assess the cord blood samples. Our processes enable us to determine the quality of your cord blood sample upon storage. In the event your cord blood sample does not meet certain important measures you will be notified immediately to discuss your options.
|
Measure |
Description |
|
Total Cell Count |
The number of total nucleated cells in your cord blood sample |
|
Viability |
The percentage of cells which are able to replicate and grow |
|
Stem Cell Count |
The number of stem cells in your cord blood sample |
Cell Care provides a safe and secure environment for your baby’s cord blood and tissue stem cells with access restricted to authorised personnel. Cell Care’s laboratories, environment and samples are monitored 24/7 for storage temperature, fire and security. Early warning systems are in place to identify any potential problem long before cells could be impacted.
Cell Care is a member of the Victoria Consortium for Cellular Therapies (VCCT). Cell Care houses multiple advanced optipress machines, cell impedance counters and flow cytometry equipment to meet all regulatory and scientific requirements for cell storage. We have invested in technology to maximise the likelihood of storing cord blood even in the event of lower volumes.
Cell Care operates according to the highest level of quality management systems. All of Cell Care’s processes are structured in accordance with the Australian code of Good Manufacturing Practice (cGMP) and the Foundation of Accredited Cellular Therapies standard (FACT/ Netcord). Cell Cares’ processes aim to ensure full product compliance, traceability and quality control of your baby’s cord blood and tissue.
Cell Care is a 100% privately owned Australian company. All cord blood and tissue products are stored on site in our state of the art facility. The company is experiencing exponential growth as cord blood and tissue storage becomes commonplace in both Australia and New Zealand. Our key investors have a strong commitment to the Australian and New Zealand health care and medical research sectors.